Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Eton Pharmaceuticals (ETON) Tax Provisions (2023 - 2025)

Eton Pharmaceuticals (ETON) has disclosed Tax Provisions for 3 consecutive years, with -$69000.0 as the latest value for Q4 2025.

  • Quarterly Tax Provisions fell 179.31% to -$69000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $43000.0 through Dec 2025, up 186.67% year-over-year, with the annual reading at $43000.0 for FY2025, 186.67% up from the prior year.
  • Tax Provisions hit -$69000.0 in Q4 2025 for Eton Pharmaceuticals, down from -$28000.0 in the prior quarter.
  • In the past five years, Tax Provisions ranged from a high of $247000.0 in Q4 2023 to a low of -$126000.0 in Q3 2024.
  • Historically, Tax Provisions has averaged $38125.0 across 3 years, with a median of $60000.0 in 2024.
  • Biggest YoY gain for Tax Provisions was 77.78% in 2025; the steepest drop was 179.31% in 2025.
  • Year by year, Tax Provisions stood at $247000.0 in 2023, then plummeted by 64.78% to $87000.0 in 2024, then tumbled by 179.31% to -$69000.0 in 2025.
  • Business Quant data shows Tax Provisions for ETON at -$69000.0 in Q4 2025, -$28000.0 in Q3 2025, and $66000.0 in Q2 2025.